N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide

C104H102F11N15O13 — CID 158661493

About N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide

N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide (PubChem CID 158661493) has the molecular formula C104H102F11N15O13 and a molecular weight of 1979.03 g/mol. Its IUPAC name is N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide.

Molecular Properties

• Compound Name: N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide
• PubChem CID: 158661493
• Molecular Formula: C104H102F11N15O13
• Molecular Weight: 1979.03 g/mol
• Exact Mass: 1977.76
• IUPAC Name: N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide
• SMILES: CCc1ccc(CC(NC(C)=O)c2nnc(-c3ccc(F)c(OC(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(C(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(OC(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(OC)c3)o2)cc1
• InChI: InChI=1S/C21H19F4N3O3.C21H20F3N3O3.C21H20F3N3O2.C21H23N3O3.C20H20FN3O2/c1-3-13-4-6-14(7-5-13)10-17(26-12(2)29)20-28-27-19(30-20)15-8-9-16(22)18(11-15)31-21(23,24)25;1-3-14-7-9-15(10-8-14)11-18(25-13(2)28)20-27-26-19(29-20)16-5-4-6-17(12-16)30-21(22,23)24;1-3-14-7-9-15(10-8-14)11-18(25-13(2)28)20-27-26-19(29-20)16-5-4-6-17(12-16)21(22,23)24;1-4-15-8-10-16(11-9-15)12-19(22-14(2)25)21-24-23-20(27-21)17-6-5-7-18(13-17)26-3;1-3-14-7-9-15(10-8-14)11-18(22-13(2)25)20-24-23-19(26-20)16-5-4-6-17(21)12-16/h4-9,11,17H,3,10H2,1-2H3,(H,26,29);4-10,12,18H,3,11H2,1-2H3,(H,25,28);4-10,12,18H,3,11H2,1-2H3,(H,25,28);5-11,13,19H,4,12H2,1-3H3,(H,22,25);4-10,12,18H,3,11H2,1-2H3,(H,22,25)
• InChIKey: ICUUUCMREGFXLP-UHFFFAOYSA-N
• XLogP: 21.70
• TPSA: 367.79 Ų
• H-Bond Donors: 5
• H-Bond Acceptors: 23
• Rotatable Bonds: 33
• Heavy Atoms: 143
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	1979.03
LogP ≤ 5	21.70
H-Bond Donors ≤ 5	5
H-Bond Acceptors ≤ 10	23

Frequently Asked Questions

What is the IUPAC name of N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide?

The IUPAC name of N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide (CID 158661493) is N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide.

What is the SMILES notation for N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide?

The canonical SMILES for N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide is CCc1ccc(CC(NC(C)=O)c2nnc(-c3ccc(F)c(OC(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(C(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(OC(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(OC)c3)o2)cc1.

What is the InChIKey of N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide?

The InChIKey is ICUUUCMREGFXLP-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H19F4N3O3.C21H20F3N3O3.C21H20F3N3O2.C21H23N3O3.C20H20FN3O2/c1-3-13-4-6-14(7-5-13)10-17(26-12(2)29)20-28-27-19(30-20)15-8-9-16(22)18(11-15)31-21(23,24)25;1-3-14-7-9-15(10-8-14)11-18(25-13(2)28)20-27-26-19(29-20)16-5-4-6-17(12-16)30-21(22,23)24;1-3-14-7-9-15(10-8-14)11-18(25-13(2)28)20-27-26-19(29-20)16-5-4-6-17(12-16)21(22,23)24;1-4-15-8-10-16(11-9-15)12-19(22-14(2)25)21-24-23-20(27-21)17-6-5-7-18(13-17)26-3;1-3-14-7-9-15(10-8-14)11-18(22-13(2)25)20-24-23-19(26-20)16-5-4-6-17(21)12-16/h4-9,11,17H,3,10H2,1-2H3,(H,26,29);4-10,12,18H,3,11H2,1-2H3,(H,25,28);4-10,12,18H,3,11H2,1-2H3,(H,25,28);5-11,13,19H,4,12H2,1-3H3,(H,22,25);4-10,12,18H,3,11H2,1-2H3,(H,22,25).

What are the key properties of N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide?

N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide has a molecular weight of 1979.03 g/mol, XLogP of 21.70, 33 rotatable bonds, 5 hydrogen bond donors, and 23 hydrogen bond acceptors.

Where does this data come from?

All data for N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide is sourced from PubChem (CID 158661493), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).